NEW YORK – Seattle-based BrainChild Bio announced Friday that it is advancing its leading drug candidate, a CAR T-cell therapy targeting the immune checkpoint B7-H3 to a registrational trial, to ...

Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...

Scientists have the technology to grow humans in Petri dishes, but they say there are better uses for it: to combat aging.

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

New research suggests that lingering cell wall fragments from the Lyme disease bacterium, Borrelia burgdorferi, may be responsible for persistent symptoms long after antibiotic treatment.

Two major studies from Harvard and MIT uncover a surprising link between the immune system and the brain, revealing how ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

The young biotech, sprung out of a Versant incubator in Switzerland, has a pair of antibody drugs it claims to have the ...